Join our mailing list to receive the latest updates and alerts Flag Subscribe

In addition to the COVID-19 Prioritized Trademark Examination Program initiated by the United States Patent and Trademark Office (USPTO) in June of 2020, the USPTO is now launching a Pilot Prioritized Review Program for Appeals Related to COVID-19 where the Trademark Trial and Appeal Board (TTAB) will expedite the review and issuance of ex parte appeal decisions for applications examined under the COVID-19 Prioritized Trademark Examination Program.

The USPTO will also launch a Conference Pilot Program for Oppositions Against Applications Related to COVID-19 where a TTAB attorney or judge may participate in the parties’ mandatory settlement and discovery planning conference, if the involved application was examined under the COVID-19 Prioritized Trademark Examination Program.

These changes are welcomed given the need to quickly get medical products and services to market in response to COVID-19.

For more information, contact a member of the Advertising, Marketing & Trademark Group.

Professionals

Jump to Page

Fredrikson & Byron, P.A. stores cookies on your device to enhance site navigation, make your browsing experience as useful as possible, and analyze site usage. By accessing this website with cookies enabled in your web browser, you agree to the storing of cookies on your device. Please read our Privacy Policy and our Disclaimer.